— McKesson Corporation (NYSE: MCK) reported its third-quarter 2020 adjusted earnings of $3.81 per share versus $3.56 per share expected.
— Total revenue rose by 5% to $59.17 billion versus $59.36 billion expected.
— On an FX-adjusted basis, revenues grew by 6%, primarily driven by growth in the US Pharmaceutical and Specialty Solutions segment, largely due to branded pharmaceutical price increases and higher volumes from retail national account customers.
— Revenues from the US Pharma segment increased by 6% driven by branded pharmaceutical price increases and increased volumes from retail national account customers.
— European Pharmaceutical Solutions segment revenue remained flat on a reported basis and up 3% on an FX-adjusted basis, driven primarily by growth in the pharmaceutical distribution business.
— Revenue from the Medical-Surgical Solutions segment increased by 6% driven by higher pharmaceutical volumes and an early start to the influenza season.
— The company reaffirmed fiscal 2020 adjusted EPS guidance range of $14.60–14.80. The consensus estimates EPS of $14.70 for the full year.
Discount store chain Dollar General Corporation (NYSE: DG) will be reporting third-quarter results next week. Operating nearly 20,000 stores across the US, it is one of the largest supermarket chains
Shares of Dollar Tree, Inc. (NASDAQ: DLTR) were up over 1% on Thursday. The stock has dropped 13% year-to-date. The discount retailer delivered third-quarter 2023 earnings results that did not
The Kroger Co. (NYSE: KR) reported its third quarter 2023 earnings results today. Total company sales were $34 billion compared to $34.2 billion for the same period last year. Identical sales